Lexicon Pharmaceuticals, Inc. (LXRX)
1.82
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.825
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Net Income (Quarterly) : -31.78M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -31.78M |
| March 31, 2026 | -1.043M |
| December 31, 2025 | -15.53M |
| September 30, 2025 | -12.77M |
| June 30, 2025 | 3.252M |
| March 31, 2025 | -25.30M |
| December 31, 2024 | -33.77M |
| September 30, 2024 | -64.81M |
| June 30, 2024 | -53.43M |
| March 31, 2024 | -48.40M |
| December 31, 2023 | -48.24M |
| September 30, 2023 | -50.52M |
| June 30, 2023 | -44.90M |
| March 31, 2023 | -31.93M |
| December 31, 2022 | -30.49M |
| September 30, 2022 | -23.39M |
| June 30, 2022 | -24.59M |
| March 31, 2022 | -23.48M |
| December 31, 2021 | -25.61M |
| September 30, 2021 | -23.12M |
| June 30, 2021 | -18.07M |
| March 31, 2021 | -20.96M |
| December 31, 2020 | -5.495M |
| September 30, 2020 | 82.60M |
| June 30, 2020 | -69.07M |
| Date | Value |
|---|---|
| March 31, 2020 | -66.61M |
| December 31, 2019 | -51.14M |
| September 30, 2019 | 226.09M |
| June 30, 2019 | -23.02M |
| March 31, 2019 | -21.80M |
| December 31, 2018 | -16.78M |
| September 30, 2018 | -27.40M |
| June 30, 2018 | -34.55M |
| March 31, 2018 | -41.82M |
| December 31, 2017 | -28.38M |
| September 30, 2017 | -30.72M |
| June 30, 2017 | -35.06M |
| March 31, 2017 | -34.89M |
| December 31, 2016 | -32.42M |
| September 30, 2016 | -36.02M |
| June 30, 2016 | -38.11M |
| March 31, 2016 | -34.88M |
| December 31, 2015 | 86.75M |
| September 30, 2015 | -35.28M |
| June 30, 2015 | -28.07M |
| March 31, 2015 | -28.08M |
| December 31, 2014 | -2.933M |
| September 30, 2014 | -40.50M |
| June 30, 2014 | -26.03M |
| March 31, 2014 | -30.84M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.316B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.692M |
| Total Expenses (Quarterly) | 32.47M |
| EPS Diluted (Quarterly) | -0.0726 |
| Enterprise Value | 678.42M |
| Gross Profit Margin (Quarterly) | 79.62% |
| Profit Margin (Quarterly) | -4.59K% |
| Earnings Yield | -8.41% |
| Normalized Earnings Yield | -8.028 |